G2GBIO Inc. (KOSDAQ:456160)
South Korea · Delayed Price · Currency is KRW 36,600
-1,300 (-3.43%)
At close: Oct 29, 2026
G2GBIO Market Cap
G2GBIO has a market cap or net worth of 608.64 billion as of October 28, 2026. It is the 14,811th most valuable company in the world and the 378th biggest in South Korea. Its market cap has decreased by 36.12% in one year.
Market Cap
608.64B
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#378 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since August 14, 2025, G2GBIO's market cap has increased from 503.30B to 608.64B, an increase of 20.93%. That is a compound annual growth rate of 17.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2026 | 608.64B | -44.68% |
| Dec 30, 2025 | 1.10T | 118.59% |
| Aug 14, 2025 | 503.30B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ImmuneOncia Therapeutics | 258.67B |
| HEM Pharma | 203.66B |
| GC WellBeing | 196.98B |
| Vivozon Pharmaceutical | 178.09B |
| DAE HWA Pharmaceutical | 176.12B |
| NOVAREX | 156.02B |
| CellBion | 146.09B |
| Kyung Dong Pharmaceutical | 145.47B |